Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 24%
Buy 62%
Hold 10%
Sell 5%
Strong Sell 0%

Bulls say

UnitedHealth Group is well-positioned in the healthcare industry, with its size, diversification, and leadership in multiple segments driving strong growth potential. Its Optum businesses complement its insurance assets and offer additional opportunities, such as data analytics and pharmaceutical benefits. Downside risks include potential Medicare Advantage reimbursement cuts and increased competition, but overall, its strong financials and strategic investments make it a compelling long-term opportunity for investors.

Bears say

UnitedHealth Group is facing potential near-term risks in its Medicaid and Medicare Advantage businesses due to legislative and regulatory changes. Additionally, the company's risk model changes and potential increases in commercial and Medicaid costs could further complicate their financial story. On the upside, UnitedHealth may see margin expansion through prudent pricing actions and plan exits, and there is potential for faster-than-expected growth in their Optum division. However, the current valuation reflects a premium that may not be sustainable in the long term, and there may be additional challenges in fully capitalizing on Optum's potential.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 62% recommend Buy, 10% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $402.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $402.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.